Related Experiment Videos
Facilitators, barriers and intervention strategies for medication adherence in patients receiving thyroid hormone
Huiting Gao1, Huan Chen1, Xinyu Chen1
1Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Statements Of Contribution:
What is already known on this subject? The standard treatment for patients with hypothyroidism is THRT, which offers numerous advantages.Many original studies have explored the factors influencing medication adherence regarding THRT; however, reviews and systematic syntheses on this topic remain limited.Previous studies on THRT adherence have often lacked a systematic framework or theoretical integration; therefore, the extent to which they address barriers to and facilitators of adherence remains unclear.What does this study add? We employed a mixed-methods approach, integrating perspectives from key stakeholders (e.g., patients, healthcare providers) to explore factors influencing medication adherence in patients undergoing THRT.The top three significant barriers were inconvenient administration times, lack of disease knowledge and lack of medication knowledge. The top three facilitators were older age, regular follow-up and positive anticipated outcomes.The study highlights the interplay of individual, interpersonal, healthcare and socioeconomic factors, emphasizing that barriers and facilitators are context dependent and often interrelated. Implementing effective adherence strategies requires collaborative efforts across stakeholders to address these multifaceted challenges.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Therapeutic Drug Monitoring: Affecting Factors
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Hypothyroidism II: Pathophysiology